Literature DB >> 14237428

MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION.

J W HURST, E A PAULK, H D PROCTOR, R C SCHLANT.   

Abstract

Entities:  

Keywords:  AURICULAR FIBRILLATION; CORONARY DISEASE; DIGITALIS GLYCOSIDES; DRUG THERAPY; ELECTRIC COUNTERSHOCK; GERIATRICS; HYPERTENSION; HYPERTHYROIDISM; MYOCARDIAL DEPRESSANTS; PULMONARY EMBOLISM; PULMONARY HEART DISEASE; QUINIDINE; RHEUMATIC HEART DISEASE; SYPHILIS, CARDIOVASCULAR

Mesh：

Substances：

Year:  1964        PMID： 14237428     DOI： 10.1016/0002-9343(64)90021-x

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  19 in total

Review 1.  Cardioversion in atrial fibrillation: indications, thromboembolic prophylaxis, and role of transesophageal echocardiography.

Authors:  M L Main; A L Klein
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

2.  Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1967-11

3.  Antiarrhythmic agents. II. Therapeutic considerations.

Authors:  D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate.

Authors:  E Byrne-Quinn; A J Wing
Journal:  Br Heart J       Date:  1970-05

5.  Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine.

Authors:  J I Hall; D R Wood
Journal:  Br Heart J       Date:  1968-01

6.  Long-term results of DC reversion of atrial fibrillation.

Authors:  M D Radford; D W Evans
Journal:  Br Heart J       Date:  1968-01

7.  Appraisal of electroconversion in treatment of cardiac dysrhythmias.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1968-11

8.  Non-synchronized direct-current countershock in cardiac arrhythmias.

Authors:  D Kavanagh-Gray
Journal:  Can Med Assoc J       Date:  1967-06-03       Impact factor: 8.262

9.  Hemodynamic effects after conversion of arrhythmias.

Authors:  R J Corliss; D H McKenna; C W Crumpton; G G Rowe
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

10.  Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.

Authors:  F Bellandi; R P Dabizzi; F Cantini; M D Natale; L Niccoli
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.